In this issue:
Adulthood height after childhoodonset IBD
Vedolizumab for perianal CD
Calcineurin inhibitor induction followed by vedolizumab maintenance in UC
Long-term budesonide and osteoporotic fracture risk in microscopic colitis
HSTCL during biologic therapy for IBD
IBD medication adherence during pregnancy
Hormone cancer therapy increases IBD relapse risk
Decreased CD reoperation rates since introduction of anti-TNFs
Fatigue and biologic therapy initiation in IBD
Please login below to download this issue (PDF)